Dexcom (DXCM) Net Margin Growth (3y) (2013 - 2026)
Dexcom (DXCM) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 300.00 |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 574.00 |
| Mar 31, 2026 | 1,018.00 |
| Dec 31, 2025 | 996.00 |
| Sep 30, 2025 | 1,032.00 |
| Jun 30, 2025 | 823.00 |
| Mar 31, 2025 | -530.00 |
| Dec 31, 2024 | 1,438.00 |
| Sep 30, 2024 | 11.00 |
| Jun 30, 2024 | 111.00 |
| Mar 31, 2024 | 471.00 |
| Dec 31, 2023 | -4,752.00 |
| Sep 30, 2023 | -203.00 |
| Jun 30, 2023 | 305.00 |
| Mar 31, 2023 | 164.00 |
| Dec 31, 2022 | -877.00 |
| Sep 30, 2022 | 159.00 |
| Jun 30, 2022 | 1,043.00 |
| Mar 31, 2022 | 2,506.00 |
| Dec 31, 2021 | 5,241.00 |
| Sep 30, 2021 | -405.00 |